AKR1C3 and polycystic ovary syndrome: This showed significantly increased AKR1C3 messenger RNA expression in subcutaneous fat from PCOS women (mean Δct, 12.1 ± 0.2 in PCOS vs 13.1 ± 0.4 in controls, P = 0.04) [Fig. 1(h)].